Middle Ear Adenomatous Neuroendocrine Tumor: A Rare Entity.


Journal

Ear, nose, & throat journal
ISSN: 1942-7522
Titre abrégé: Ear Nose Throat J
Pays: United States
ID NLM: 7701817

Informations de publication

Date de publication:
Dec 2023
Historique:
pubmed: 22 7 2021
medline: 22 7 2021
entrez: 21 7 2021
Statut: ppublish

Résumé

Middle ear adenomatous neuroendocrine tumors (MEANT) are rare, mainly benign neoplasms and account for less than 2% of the middle and inner ear neoplasms. There are no specific radiological or clinical findings; therefore, the diagnosis is often difficult. Biopsy prior to surgery is often proposed. The definite treatment is the complete surgical resection. We present an uncommon clinical report of a MEANT, which was treated successfully with surgical excision.

Identifiants

pubmed: 34284607
doi: 10.1177/01455613211029785
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

NP585-NP587

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Katerina Marini (K)

Department of ORL, Head and Neck Surgery, "G. Gennimatas" General Hospital, Thessaloniki, Greece.

Konstantinos Garefis (K)

2nd Academic ORL, Head and Neck Surgery Department, Aristotle University of Thessaloniki, Papageorgiou Hospital, Thessaloniki, Greece.

James Philip Skliris (JP)

Department of Pathology, "Theageneion" Cancer Hospital, Thessaloniki, Greece.

Astreinidou Anna (A)

Department of ORL, Head and Neck Surgery, "G. Gennimatas" General Hospital, Thessaloniki, Greece.

Jiannis Hajiioannou (J)

Department of ORL, Head and Neck Surgery, University Hospital of Larissa, Larissa, Greece.

Vasiliki Florou (V)

Department of ORL, Head and Neck Surgery, "G. Gennimatas" General Hospital, Thessaloniki, Greece.

Classifications MeSH